Human Bcl-2 ELISA Kit

$245.00 – $350.00

Related Target	BCL2
Species	human
Sample Type	Serum, plasma, cell culture supernatant, and other biological samples
Sample Volume	80 μL 1×Assay Buffer and 20 μL sample
Sensitivity	50.25 pg/mL
Array Range	0.47 ng/mL – 30 ng/mL
Assay Time	3.5 h
Recovery	90% – 110%
Average Recovery	99%

ELISA Kit Detail Information

Related Target	BCL2
Species	human
Sample Type	Serum, plasma, cell culture supernatant, and other biological samples
Sample Volume	80 μL 1×Assay Buffer and 20 μL sample
Sensitivity	50.25 pg/mL
Array Range	0.47 ng/mL – 30 ng/mL
Assay Time	3.5 h
Recovery	90% – 110%
Average Recovery	99%
Intra Precision	4.0% – 4.9%
Inter Precision	2.4% – 4.7%
Plate	Detachable 96-well plate
Storage	If the reagent kit is unopened, it should be stored at 4℃. However, if it has been opened, the standard solution should be stored at -20℃, while the other components should be stored at 4℃.
Delivery	4℃ blue ice transportation
Components	96-well polystyrene enzyme-linked immunosorbent assay (ELISA) plate coated with anti-Bcl-2 monoclonal antibody Human Bcl-2 freeze-dried standard Bcl-2 detect Antibody Standard Diluent Assay Buffer(10×) Substrate TMB Stop Solution Washing Buffer(20×) Sealing Film
Assay Principle	This kit utilizes the double antibody sandwich enzyme-linked immunosorbent assay (ELISA) detection technique.Specific anti-human Bcl-2 antibodies are precoated on a high-affinity ELISA plate. Standard samples, test samples, and the detection antibody labeled with horseradish peroxidase are added to the wells of the ELISA plate. After incubation, Bcl-2 present in the samples binds to the solid-phase antibody and the detection antibody. After washing, a colorimetric substrate, TMB, is added and the plate is incubated in the dark for color development. The intensity of the color reaction is directly proportional to the concentration of Bcl-2 in the samples.A stop solution is added to terminate the reaction, and the absorbance value is measured at a wavelength of 450 nm (with a reference wavelength range of 570-630 nm).

Related Targets

BCL2

BCL2 Target Infomation Overview

Target Symbol: BCL2, BCL2 apoptosis regulator
Gene Groups: Protein phosphatase 1 regulatory subunits; BCL2 family
Alias: Bcl-2; PPP1R50
Alias Names: protein phosphatase 1, regulatory subunit 50; B-cell CLL/lymphoma 2; BCL2, apoptosis regulator

BCL2, BCL2 apoptosis regulator Target Infomation by Species

Human
Mouse
Rat

Human BCL2 Target Information

Target Symbol: BCL2, BCL2 apoptosis regulator
Alias:
- apoptosis regulator Bcl-2
- B-cell CLL/lymphoma 2
- b-cell leukemia/lymphoma 2
- Bcl-2
- Bcl-2a
- Bcl-2ß
- BCL2, apoptosis regulator
- PPP1R50
- protein phosphatase 1, regulatory subunit 50
NCBI_Gene: 596
UniProtKB: P10415

Human BCL2 Predicted Functions

Enables several functions, including BH3 domain binding activity; enzyme binding activity; and protein heterodimerization activity. Involved in several processes, including B cell receptor signaling pathway; negative regulation of apoptotic process; and positive regulation of B cell proliferation. Acts upstream of or within several processes, including B cell proliferation; apoptotic signaling pathway; and negative regulation of apoptotic process. Located in endoplasmic reticulum; mitochondrial outer membrane; and nucleus. Part of pore complex. Implicated in several diseases, including carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; prostate cancer; and urinary bladder cancer. Biomarker of several diseases, including cervix uteri carcinoma in situ; ductal carcinoma in situ; gastrointestinal system cancer (multiple); hematologic cancer (multiple); and urinary system cancer (multiple).

Mouse Bcl2 Target Information

Target Symbol: Bcl2, B cell leukemia/lymphoma 2
Alias:
- AW986256
- Bcl-2
- C430015F12Rik
- D630044D05Rik
- D830018M01Rik
- expressed sequence AW986256
- RIKEN cDNA C430015F12 gene
- RIKEN cDNA D630044D05 gene
- RIKEN cDNA D830018M01 gene
NCBI_Gene: 12043

Mouse Bcl2 Predicted Functions

Enables protein phosphatase 2A binding activity. Involved in several processes, including hair follicle morphogenesis; mitochondrion organization; and negative regulation of reactive oxygen species metabolic process. Acts upstream of or within several processes, including animal organ development; apoptotic signaling pathway; and negative regulation of programmed cell death. Located in several cellular components, including mitochondrial membrane; myelin sheath; and nuclear membrane. Is expressed in several structures, including central nervous system; genitourinary system; gut; limb; and sensory organ. Used to study oligomeganephronia. Human ortholog(s) of this gene implicated in several diseases, including Alzheimer’s disease; carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; and prostate cancer. Orthologous to human BCL2 (BCL2 apoptosis regulator).

Rat Bcl2 Target Information

Target Symbol: Bcl2, BCL2, apoptosis regulator
Alias:
- apoptosis regulator Bcl-2
- B cell lymphoma 2 associated oncogene
- B-cell CLL/lymphoma 2
- B-cell leukemia/lymphoma 2
- Bcl-2
- Bcl-2alpha
- Bcl2-like protein
NCBI_Gene: 24224

Rat Bcl2 Predicted Functions

Enables BH domain binding activity. Involved in several processes, including response to peptide; response to purine-containing compound; and response to vitamin. Located in cytosol; mitochondrial crista; and perinuclear region of cytoplasm. Used to study several diseases, including brain ischemia (multiple); end stage renal disease; gastric ulcer; intestinal disease (multiple); and status epilepticus. Biomarker of several diseases, including abdominal obesity-metabolic syndrome 1; brain disease (multiple); hypertension (multiple); intrinsic cardiomyopathy (multiple); and neurodegenerative disease (multiple). Human ortholog(s) of this gene implicated in several diseases, including carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; prostate cancer; and urinary bladder cancer. Orthologous to human BCL2 (BCL2 apoptosis regulator).

Citations for Human Bcl-2 ELISA Kit

There are no citations for this product yet.

If you buy this product and mention it in your thesis, we welcome you to provide us with the thesis information. As a thank you, we will give you some gifts, such as discount coupons.

Citations data is updating...

Competitive ELISA: Principles, Methods, and Key Differences

Competitive ELISA is a widely used immunoassay technique for quantifying target analytes in samples by measuring their interference with a known signal. This method is based on the principle of limited antibodies, where the target analyte competes with a labeled antigen for antibody binding. Competitive ELISA is commonly used for detecting small molecules with fewer epitopes and is available in direct and indirect formats. This article explains the fundamental principles, experimental workflow, and key differences between direct and indirect competitive ELISA, helping researchers choose the optimal method for their applications.

ELISA (Enzyme-Linked Immunosorbent Assay): Principle, Types, and Step-by-Step Protocol

Learn about ELISA (Enzyme-Linked Immunosorbent Assay), a highly sensitive immunoassay technique used in medical diagnostics and biopharmaceuticals. This guide covers its principles, common types (sandwich, direct, indirect, competitive), detailed protocol, and key considerations for accurate results.

ELISA Blood Samples: Serum vs Plasma - Key Differences, Preparation & Hemolysis Effects

Learn whether to use serum or plasma for ELISA testing, including preparation protocols, key differences (fibrinogen, clotting factors), and how hemolysis impacts results. Essential guide for accurate immunoassays.